Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Icosapent Ethyl recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Icosapent Ethyl (3 total). Check the affected lots below.

Most common reason: Failed specification (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Icosapent Ethyl. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Icosapent Ethyl recalls in 2026

1 initiated in 2026, 3 in total — newest first
Class II · Moderate risk

Icosapent Ethyl Capsules

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Ongoing Failed specification Zydus Pharmaceuticals (USA) Inc D-0400-2026
Class II · Moderate risk

Icosapent Ethyl capsules

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Ongoing Wrong potency / content Zydus Pharmaceuticals (USA) Inc NDC 70710-1592-07 D-0295-2026
Class II · Moderate risk

Icosapent Ethyl Capsules 1 gram

Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.

Completed Failed specification Zydus Pharmaceuticals (USA) Inc NDC 70710-1592-7 D-0497-2025